Macrophages play important roles in tissue homeostasis, host defense, response to injury, tissue repair, and resolution of inflammation. The long term goals of this project are to understand how macrophage functional phenotypes are regulated to balance host defense and inflammation with homeostatic functions that resolve inflammation and restore tissue integrity. An associated goal is to therapeutically modulate macrophages to promote tissue repair while minimizing inflammatory pathology. Macrophages assume various phenotypes dependent on ontogeny, tissue-specific factors, epigenetic programming, and (micro)environmental challenges. Inflammatory macrophages produce cytokines such as TNF and IL-1 that are important for host defense and inflammation, while reparative and pro-resolution macrophages produce suppressive and growth factors such as IL-10, VEGF and PDGF important for tissue repair, wound healing and resolution of inflammation. Recent high dimensional analyses using flow/mass cytometry and single cell RNA sequencing (scRNAseq) have revealed distinct macrophage populations and functional phenotypes in different tissues and disease states. Wound healing typically progresses through inflammatory, tissue repair, and tissue remodeling stages. Both inflammatory and repair phases, and a well-regulated balance and transition between them, are important for effective wound healing. Excessive inflammation, such as occurs in chronic TNF-driven inflammatory diseases such as rheumatoid arthritis (RA), results in ineffective repair and chronic wounds. Immune cells including macrophages play important roles in the first two phases of wound healing, and modulation of macrophage function to improve tissue repair is an emerging therapeutic strategy. In the previous project period we investigated mechanisms of crossregulation between the inflammatory factor TNF and the repair factor IL-4, using primary human macrophages and mouse models of wound healing. While IL-4 suppressed components of the TNF inflammatory response, the two cytokines synergized to induce genes associated with resolution of inflammation. The balance between an inflammatory and reparative macrophage phenotype was regulated in part by SREBP transcription factors. Myeloid inactivation or pharmacological inhibition of SREBPs accelerated wound healing. scRNAseq identified novel macrophage populations induced by injury and associated with tissue repair. These data provide insights into mechanisms that regulate the transition from inflammation to repair, and support our overarching hypothesis that selective modulation of the immune system can be utilized to improve tissue repair. In this project we will investigate mechanisms that regulate the balance and transition between inflammation and tissue repair. We anticipate that our studies will yield insights that can be used to develop novel therapeutic strategies to enhance wound healing and restore tissue function.

Public Health Relevance

Macrophages are immune cells that play important roles in defense against infections, inflammation, and repair of injured tissues. The long term goals of this project are to understand how macrophages are regulated to balance inflammatory and reparative functions to promote tissue repair and restore tissue integrity. This project will investigate communication between inflammatory and reparative pathways and injury-associated macrophage subtypes to gain knowledge that can be used to modulate the immune system to promote tissue repair and wound healing.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI044938-21A1
Application #
10205277
Study Section
Innate Immunity and Inflammation Study Section (III)
Program Officer
Peyman, John A
Project Start
1999-09-30
Project End
2026-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
21
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Hospital for Special Surgery
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10021
Manni, Michela; Gupta, Sanjay; Ricker, Edd et al. (2018) Regulation of age-associated B cells by IRF5 in systemic autoimmunity. Nat Immunol 19:407-419
Loupasakis, Konstantinos; Kuo, David; Sokhi, Upneet K et al. (2017) Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes. PLoS One 12:e0179762
Park, Sung Ho; Kang, Kyuho; Giannopoulou, Eugenia et al. (2017) Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nat Immunol 18:1104-1116
Murata, Koichi; Fang, Celestia; Terao, Chikashi et al. (2017) Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis. Immunity 47:66-79.e5
Kang, Kyuho; Park, Sung Ho; Chen, Janice et al. (2017) Interferon-? Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. Immunity 47:235-250.e4
Binder, Nikolaus; Miller, Christine; Yoshida, Masaki et al. (2017) Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption. J Immunol 198:3436-3447
Ivashkiv, Lionel B; Park, Sung Ho (2016) Epigenetic Regulation of Myeloid Cells. Microbiol Spectr 4:
Qiao, Yu; Kang, Kyuho; Giannopoulou, Eugenia et al. (2016) IFN-? Induces Histone 3 Lysine 27 Trimethylation in a Small Subset of Promoters to Stably Silence Gene Expression in Human Macrophages. Cell Rep 16:3121-3129
Fang, Celestia; Qiao, Yu; Mun, Se Hwan et al. (2016) Cutting Edge: EZH2 Promotes Osteoclastogenesis by Epigenetic Silencing of the Negative Regulator IRF8. J Immunol 196:4452-4456
Foldi, Julia; Shang, Yingli; Zhao, Baohong et al. (2016) RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genes. Protein Cell 7:201-9

Showing the most recent 10 out of 46 publications